ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $767 | -5.5% | 36,840 | +9.4% | 0.00% | 0.0% |
| Q2 2023 | $812 | +33.6% | 33,666 | +4.4% | 0.00% | 0.0% |
| Q1 2023 | $608 | +14.9% | 32,244 | -2.5% | 0.00% | +100.0% |
| Q4 2022 | $529 | -99.8% | 33,074 | +66.9% | 0.00% | 0.0% |
| Q3 2022 | $324,000 | +252.2% | 19,819 | +204.7% | 0.00% | – |
| Q2 2022 | $92,000 | -45.2% | 6,505 | 0.0% | 0.00% | – |
| Q1 2022 | $168,000 | +11.3% | 6,505 | 0.0% | 0.00% | – |
| Q4 2021 | $151,000 | +38.5% | 6,505 | 0.0% | 0.00% | – |
| Q3 2021 | $109,000 | -31.4% | 6,505 | 0.0% | 0.00% | – |
| Q2 2021 | $159,000 | -25.4% | 6,505 | -21.7% | 0.00% | -100.0% |
| Q1 2021 | $213,000 | -48.9% | 8,310 | +6.1% | 0.00% | 0.0% |
| Q4 2020 | $417,000 | +29.1% | 7,829 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $323,000 | -14.6% | 7,829 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $378,000 | +13.2% | 7,829 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $334,000 | +0.6% | 7,829 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $332,000 | -14.2% | 7,829 | -46.1% | 0.00% | 0.0% |
| Q2 2019 | $387,000 | +68.3% | 14,526 | -1.6% | 0.00% | 0.0% |
| Q4 2018 | $230,000 | -6.1% | 14,758 | +25.2% | 0.00% | 0.0% |
| Q3 2018 | $245,000 | +36.1% | 11,789 | 0.0% | 0.00% | – |
| Q2 2018 | $180,000 | -32.1% | 11,789 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $265,000 | -25.1% | 11,789 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $354,000 | -21.5% | 11,789 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $451,000 | +37.5% | 11,789 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $328,000 | -18.8% | 11,789 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $404,000 | +18.1% | 11,789 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $342,000 | -54.3% | 11,789 | -50.0% | 0.00% | 0.0% |
| Q3 2016 | $748,000 | +96.3% | 23,578 | +100.0% | 0.00% | 0.0% |
| Q2 2016 | $381,000 | +46.5% | 11,789 | +26.8% | 0.00% | 0.0% |
| Q1 2016 | $260,000 | -21.7% | 9,295 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $332,000 | +7.8% | 9,295 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $308,000 | -20.6% | 9,295 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $388,000 | +28.5% | 9,295 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $302,000 | +2.7% | 9,295 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $294,000 | +27.3% | 9,295 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $231,000 | +10.5% | 9,295 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $209,000 | +161.2% | 9,295 | +182.1% | 0.00% | – |
| Q1 2014 | $80,000 | -3.6% | 3,295 | 0.0% | 0.00% | – |
| Q4 2013 | $83,000 | – | 3,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |